- Home
- RVT vs CLDX Comparison
RVT vs CLDX Comparison
Compare RVT & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RVT | CLDX |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | RVT | CLDX |
|---|---|---|
| Price | $17.35 | $25.98 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $44.10 |
| AVG Volume (30 Days) | 243.4K | ★ 763.6K |
| Earning Date | 01-01-0001 | 02-26-2026 |
| Dividend Yield | ★ 7.32% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.95 | N/A |
| Revenue | N/A | ★ $2,599,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23.23 |
| P/E Ratio | $4.98 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.85 | $14.40 |
| 52 Week High | $14.93 | $30.50 |
Technical Indicators
Market Signals| Indicator | RVT | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 73.97 | 46.29 |
| Support Level | $16.95 | $25.28 |
| Resistance Level | $17.20 | $26.99 |
| Average True Range (ATR) | 0.20 | 1.27 |
| MACD | 0.09 | -0.11 |
| Stochastic Oscillator | 99.28 | 23.52 |
Price Performance
Historical ComparisonAbout RVT Royce Value Trust Inc.
Royce Value Trust Inc is a diversified closed-end investment company. It invests in diversified sectors including consumer discretionary, consumer staples, healthcare, financial, IT, telecommunications, and materials. The company's portfolio includes common stocks, preferred stocks, corporate bonds, and repurchase agreements. The company invests in Industrials, Financials, Information Technology, Materials, Health Care, Communication Services, Real Estate and others.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.